Ehimi, Japan

Tatsuo Kokubu


Average Co-Inventor Count = 6.5

ph-index = 2

Forward Citations = 137(Granted Patents)


Location History:

  • Onsen, JP (1985)
  • Ehimi, JP (1994)
  • Ehime, JP (1987 - 1995)
  • Osakasayama, JP (1995)

Company Filing History:


Years Active: 1985-1995

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Tatsuo Kokubu

Introduction

Tatsuo Kokubu is a notable inventor based in Ehimi, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of oligopeptides with renin-inhibitory activity. With a total of 5 patents to his name, Kokubu's work has implications for the treatment of hypertension.

Latest Patents

Kokubu's latest patents include innovative compounds that exhibit renin-inhibitory properties. One of his notable inventions is a series of oligopeptides characterized by specific formulas, which demonstrate effectiveness in oral administration. These compounds are designed to inhibit renin, a key enzyme in the regulation of blood pressure. Another patent focuses on peptides that not only inhibit renin but also possess hypotensive activities, making them valuable for diagnosing and treating hypertension related to the renin-angiotensin system.

Career Highlights

Kokubu is associated with Sankyo Company, Limited, where he has been instrumental in advancing research in pharmacology. His work has contributed to the understanding of how specific amino acid sequences can influence biological activity, particularly in the context of hypertension.

Collaborations

Throughout his career, Kokubu has collaborated with esteemed colleagues such as Yuichiro Yabe and Kunio Hiwada. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries in the field.

Conclusion

Tatsuo Kokubu's contributions to the field of medicinal chemistry through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of therapeutic agents for hypertension, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…